{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:20:59Z","timestamp":1768969259367,"version":"3.49.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Phage therapy is an emerging antimicrobial treatment for critical multidrug-resistant pathogens. In this review, the specific potential and challenges of phage therapy for patients with hidradenitis suppurativa (HS) are discussed. This represents a unique challenge as HS is a chronic inflammatory disease, but presenting with acute exacerbations, which have an enormous negative impact on patient\u2019s quality of life. The therapeutic arsenal for HS has expanded in the past decade, for example, with adalimumab and several other biologicals that are currently under investigation. However, treatment of HS remains challenging for dermatologists because there are individuals who do not respond to any classes of the current treatment options when used for a first or second time. Furthermore, after several courses of treatment, a patient may lose their response to therapy, meaning long-term use is not always an option. Culturing studies and 16S ribosomal RNA profiling highlight the complex polymicrobial nature of HS lesions. Despite the detection of various bacterial species in lesion samples, several key pathogens, including Staphylococcus, Corynebacterium and Streptococcus, may be potential targets for phage therapy. Using phage therapy for the treatment of a chronic inflammatory disease could potentially provide new insights into the role of bacteria and the immune system in HS development. In addition, it is possible more details on the immunomodulatory effects of phages may come to light.<\/jats:p>","DOI":"10.1093\/ced\/llad207","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T18:09:22Z","timestamp":1686766162000},"page":"1221-1229","source":"Crossref","is-referenced-by-count":8,"title":["Phage therapy for hidradenitis suppurativa: a unique challenge and possible opportunity for personalized treatment of a complex, inflammatory disease"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8539-7996","authenticated-orcid":false,"given":"Lene","family":"Bens","sequence":"first","affiliation":[{"name":"Departments of Biosystems"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3959-2640","authenticated-orcid":false,"given":"Sabrina I","family":"Green","sequence":"additional","affiliation":[{"name":"Departments of Biosystems"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4612-6891","authenticated-orcid":false,"given":"Daan","family":"Jansen","sequence":"additional","affiliation":[{"name":"Microbiology, Immunology and Transplantation, Rega Institute , KU Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4497-8487","authenticated-orcid":false,"given":"Tom","family":"Hillary","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine","family":"Vanhoutvin","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-9733","authenticated-orcid":false,"given":"Jelle","family":"Matthijnssens","sequence":"additional","affiliation":[{"name":"Microbiology, Immunology and Transplantation, Rega Institute , KU Leuven Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-7075","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Sabino","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology , UZ Leuven, Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology , UZ Leuven, Leuven , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Van Laethem","sequence":"additional","affiliation":[{"name":"Departments of Dermatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2185-5724","authenticated-orcid":false,"given":"Jeroen","family":"Wagemans","sequence":"additional","affiliation":[{"name":"Departments of Biosystems"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7377-1314","authenticated-orcid":false,"given":"Rob","family":"Lavigne","sequence":"additional","affiliation":[{"name":"Departments of Biosystems"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2023102519564233400_llad207-B1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","article-title":"Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments","volume":"21","author":"van der Zee","year":"2012","journal-title":"Exp Dermatol"},{"key":"2023102519564233400_llad207-B2","first-page":"18","article-title":"Hidradenitis suppurativa","volume-title":"Nat Rev Dis Primers","author":"Sabat","year":"2020"},{"key":"2023102519564233400_llad207-B3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/B978-0-323-77724-7.00002-4","volume-title":"A Comprehensive Guide to Hidradenitis Suppurativa","author":"Morss-Walton","year":"2022"},{"key":"2023102519564233400_llad207-B4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis suppurativa","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology"},{"key":"2023102519564233400_llad207-B5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaad.2006.08.061","article-title":"Quality of life impairment in hidradenitis suppurativa: a study of 61 cases","volume":"56","author":"Wolkenstein","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2023102519564233400_llad207-B6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/exd.14214","article-title":"What causes hidradenitis suppurativa? 15\u2005years after","volume":"29","author":"Zouboulis","year":"2020","journal-title":"Exp Dermatol"},{"key":"2023102519564233400_llad207-B8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/bjd.14075","article-title":"Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa","volume":"173","author":"Kelly","year":"2015","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","article-title":"Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2","volume":"164","author":"van der Zee","year":"2011","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"2023102519564233400_llad207-B11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00403-015-1596-5","article-title":"Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients","volume":"307","author":"Riis","year":"2015","journal-title":"Arch Dermatol Res"},{"key":"2023102519564233400_llad207-B12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-323-77724-7.00008-5","volume-title":"A Comprehensive Guide to Hidradenitis Suppurativa","author":"Malviya","year":"2022"},{"key":"2023102519564233400_llad207-B13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MIB.0000000000000579","article-title":"Identification of clinical and genetic parameters associated with hidradenitis suppurativa in inflammatory bowel disease","volume":"22","author":"Janse","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2023102519564233400_llad207-B14","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.3748\/wjg.v22.i20.4802","article-title":"Hydradenitis suppurativa and inflammatory bowel disease: an unusual, but existing association","volume":"22","author":"Principi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2023102519564233400_llad207-B15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2023102519564233400_llad207-B16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjd.13002","article-title":"The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease","volume":"171","author":"van der Zee","year":"2014","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"2023102519564233400_llad207-B18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"9","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"key":"2023102519564233400_llad207-B19","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The follicular skin microbiome in patients with hidradenitis suppurativa and healthy controls","volume":"153","author":"Ring","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2023102519564233400_llad207-B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jid.2018.09.036","article-title":"Are bacteria infectious pathogens in hidradenitis suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017","volume":"139","author":"Naik","year":"2019","journal-title":"J Invest Dermatol"},{"key":"2023102519564233400_llad207-B21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1171700","article-title":"Topographical and temporal diversity of the human skin microbiome","volume":"324","author":"Grice","year":"2009","journal-title":"Science"},{"key":"2023102519564233400_llad207-B22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3920\/BM2012.0062","article-title":"Bacterial skin commensals and their role as host guardians","volume":"5","author":"Christensen","year":"2014","journal-title":"Benef Microbes"},{"key":"2023102519564233400_llad207-B23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jid.2019.06.151","article-title":"Loss of microbial diversity and body site heterogeneity in individuals with hidradenitis suppurativa","volume":"140","author":"Schneider","year":"2019","journal-title":"J Invest Dermatol"},{"key":"2023102519564233400_llad207-B24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2133.2011.10747.x","article-title":"Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained \u00adduring carbon dioxide laser treatment","volume":"166","author":"Sartorius","year":"2012","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B25","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jdv.15597","article-title":"The microbiome of tunnels in hidradenitis suppurativa patients","volume":"33","author":"Ring","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519564233400_llad207-B26","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jid.2019.08.445","article-title":"Skin microbiota perturbations are distinct and disease severity-dependent in hidradenitis suppurativa","volume":"140","author":"Naik","year":"2020","journal-title":"J Invest Dermatol"},{"key":"2023102519564233400_llad207-B27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1046\/j.1365-2133.1999.02613.x","article-title":"Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery","volume":"140","author":"Lapins","year":"1999","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1574-695X.2012.00946.x","article-title":"Considering hidradenitis suppurativa as a bacterial biofilm disease","volume":"65","author":"Kathju","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2023102519564233400_llad207-B29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bjd.15007","article-title":"Bacterial biofilm in chronic lesions of hidradenitis suppurativa","volume":"176","author":"Ring","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bjd.14805","article-title":"Bacterial biofilm in acute lesions of hidradenitis suppurativa","volume":"176","author":"Okoye","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023102519564233400_llad207-B31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","article-title":"Hidradenitis suppurativa","volume":"23","author":"Revuz","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519564233400_llad207-B32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anplas.2017.03.012","article-title":"Non-surgical treatments for hidradenitis suppurativa: a systematic review","volume":"62","author":"Robert","year":"2017","journal-title":"Ann Chir Plast Esthet"},{"key":"2023102519564233400_llad207-B33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.annder.2008.03.003","article-title":"[The role of surgery in the treatment of hidradenitis suppurativa]","volume":"135","author":"Revuz","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"2023102519564233400_llad207-B34","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16494","article-title":"Profile of smoking dependency in hidradenitis suppurativa patients and smoking cessation outcomes","volume":"34","author":"Deilhes","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519564233400_llad207-B35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jdcr.2018.12.002","article-title":"Secukinumab and hidradenitis suppurativa: friends or foes?","volume":"5","author":"Marasca","year":"2019","journal-title":"JAAD Case Rep"},{"key":"2023102519564233400_llad207-B36","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.18685","article-title":"Long-term secukinumab efficacy in patients with moderate to severe hidradenitis suppurativa: a retrospective single-centre case series (23 patients)","volume":"37","author":"Melgosa Ramos","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519564233400_llad207-B37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/B978-0-323-77724-7.00014-0","volume-title":"A Comprehensive Guide to Hidradenitis Suppurativa","author":"Hendricks","year":"2022"},{"key":"2023102519564233400_llad207-B38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrmicro1750","article-title":"Marine viruses\u00a0\u2013 major players in the global ecosystem","volume":"5","author":"Suttle","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"2023102519564233400_llad207-B39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.resmic.2008.05.001","article-title":"Exploring the prokaryotic virosphere","volume":"159","author":"Comeau","year":"2008","journal-title":"Res Microbiol"},{"key":"2023102519564233400_llad207-B40","first-page":"2","article-title":"Professor Dr. Richard Bruynoghe: a 1951 overview of his bacteriophage research spanning three decades","author":"Lavigne","year":"2012","journal-title":"Bacteriophage"},{"key":"2023102519564233400_llad207-B41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/v11100891","article-title":"Bacteriophage application for difficult-to-treat musculoskeletal infections: development of a standardized multidisciplinary treatment protocol","volume":"11","author":"Onsea","year":"2019","journal-title":"Viruses"},{"key":"2023102519564233400_llad207-B42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/femsre\/fuaa017","article-title":"Current challenges and future opportunities of phage therapy","volume":"44","author":"Pires","year":"2020","journal-title":"FEMS Microbiol Rev"},{"key":"2023102519564233400_llad207-B43","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin Ther"},{"key":"2023102519564233400_llad207-B44","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023102519564233400_llad207-B45","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat Commun"},{"key":"2023102519564233400_llad207-B46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002119","article-title":"Translating phage therapy into the clinic: recent accomplishments but continuing challenges","volume":"21","author":"Petrovic Fabijan","year":"2023","journal-title":"PLoS Biol"},{"key":"2023102519564233400_llad207-B47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2672.2004.02422.x","article-title":"Bacteriophage penetration in vertebrates","volume":"98","author":"Dabrowska","year":"2005","journal-title":"J Appl Microbiol"},{"key":"2023102519564233400_llad207-B48","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1007\/s11095-010-0313-5","article-title":"The phage therapy paradigm: pr\u00eat-\u00e0-porter or sur-mesure?","volume":"28","author":"Pirnay","year":"2011","journal-title":"Pharm Res"},{"key":"2023102519564233400_llad207-B49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2009.03.006","article-title":"Phage therapy","volume":"14","author":"Housby","year":"2009","journal-title":"Drug Discov Today"},{"key":"2023102519564233400_llad207-B50","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","article-title":"Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation","volume":"185","author":"Federici","year":"2022","journal-title":"Cell"},{"key":"2023102519564233400_llad207-B51","first-page":"241","article-title":"Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway","volume":"48","author":"Dabrowska","year":"2004","journal-title":"Acta Virol"},{"key":"2023102519564233400_llad207-B52","doi-asserted-by":"crossref","first-page":"e51813","DOI":"10.1371\/journal.pone.0051813","article-title":"Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"2023102519564233400_llad207-B53","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03474-20","article-title":"Targeting of mammalian glycans enhances phage predation in the gastrointestinal tract","volume":"12","author":"Green","year":"2021","journal-title":"mBio"},{"key":"2023102519564233400_llad207-B54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s12275-011-1512-4","article-title":"Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models","volume":"49","author":"Tiwari","year":"2011","journal-title":"J Microbiol"},{"key":"2023102519564233400_llad207-B55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2023102519564233400_llad207-B56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"key":"2023102519564233400_llad207-B57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9691","article-title":"Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection","volume":"363","author":"Sweere","year":"2019","journal-title":"Science"},{"key":"2023102519564233400_llad207-B58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00430-006-0011-4","article-title":"Effects of bacteriophages on free radical production and phagocytic functions","volume":"195","author":"Przerwa","year":"2006","journal-title":"Med Microbiol Immunol"},{"key":"2023102519564233400_llad207-B59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08336-9","article-title":"Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages","volume":"7","author":"Van Belleghem","year":"2017","journal-title":"Sci Rep"},{"key":"2023102519564233400_llad207-B60","volume-title":"A Literature Review of the Practical Application of Bacteriophage Research","author":"Chanishvili","year":"2012"},{"key":"2023102519564233400_llad207-B61","author":"Bacteriophage.news"},{"key":"2023102519564233400_llad207-B62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/00222615-48-1-103","article-title":"Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa","volume":"48","author":"Brook","year":"1999","journal-title":"J Med Microbiol"},{"key":"2023102519564233400_llad207-B63","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3201\/eid2012.140064","article-title":"Bacterial pathogens associated with hidradenitis suppurativa, France","volume":"20","author":"Guet-Revillet","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2023102519564233400_llad207-B64","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2340\/00015555-1841","article-title":"Bacteriology of hidradenitis suppurativa \u2013 which antibiotics are the treatment of choice?","volume":"94","author":"Matusiak","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"2023102519564233400_llad207-B65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000381959","article-title":"Aerobic and anaerobic bacteriology of hidradenitis suppurativa: a study of 22 cases","volume":"1","author":"Katoulis","year":"2015","journal-title":"Skin Appendage Disord"},{"key":"2023102519564233400_llad207-B66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000446812","article-title":"Microbial profile and antimicrobial susceptibility of bacteria found in inflammatory hidradenitis suppurativa lesions","volume":"29","author":"Hessam","year":"2016","journal-title":"Skin Pharmacol Physiol"},{"key":"2023102519564233400_llad207-B67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jamadermatol.2016.2337","article-title":"Prevalence of firmicutes in lesions of hidradenitis suppurativa in obese patients","volume":"152","author":"Haskin","year":"2016","journal-title":"JAMA Dermatol"},{"key":"2023102519564233400_llad207-B68","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/00015555-2591","article-title":"Bacterial colonization in hidradenitis suppurativa\/acne inversa: a cross-sectional study of 50 patients and review of the literature","volume":"97","author":"Nikolakis","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2023102519564233400_llad207-B69","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/jdv.15332","article-title":"Rates of antibiotic resistance\/sensitivity in bacterial cultures of hidradenitis suppurativa patients","volume":"33","author":"Bettoli","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023102519564233400_llad207-B70","doi-asserted-by":"crossref","first-page":"459","DOI":"10.23736\/S0392-0488.18.05875-3","article-title":"Hidradenitis suppurativa\/acne inversa: a prospective bacteriological study and review of the literature","volume":"155","author":"Benzecry","year":"2020","journal-title":"G Ital Dermatol Venereol"},{"key":"2023102519564233400_llad207-B71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study","volume":"65","author":"Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad207\/51107843\/llad207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/11\/1221\/52548795\/llad207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/11\/1221\/52548795\/llad207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T19:58:19Z","timestamp":1698263899000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/11\/1221\/7197860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6,14]]},"published-print":{"date-parts":[[2023,10,25]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad207","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,6,14]]}}}